Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Dior Faces Backlash Over Bella Hadid’s Replacement with Israeli Model

tenbizt Views  

Palestinian model Bella Hadid
has been working as a Dior model since 2016
Recent model change at Dior sparks controversy

Instagram@bellahadid

The brand Christian Dior is at the center of controversy after changing its model.

Recently, luxury fashion brand Christian Dior has been reported to have replaced Palestinian model Bella Hadid with Israeli model May Tager.

While not confirmed, attention has been drawn to the fact that May Tager was acknowledged as the model for Dior’s end-of-year holiday season campaign.

Amid this, Bella Hadid, who became the first Dior promotional model from Palestine in 2016, is attracting attention.

Online Community

Bella Hadid is well-known for supporting Palestine alongside her father and sister, and after becoming a Dior model, she has raised her voice even more for advocating Palestinian rights.

Furthermore, she showed more active movements after the Hamas attack last October.

Some netizens are speculating that Dior’s decision to replace Palestinian model Bella Hadid with Israeli May Tager might indicate support for Israel.

Instagram@bellahadid / Instagram@maytager

Online, the atmosphere is beginning to believe in this speculation, and there are even movements for comments and boycotts against Dior.

However, some media outlets claim that Bella Hadid’s contract with Dior ended last March and that May Tager has also consistently been a Dior campaign model.

There are reports of corrections and explanations regarding this matter, but there are mixed reactions on online communities and social media, and the debate among netizens continues.

By. Han Ji Myeong

tenbizt
content@viewusglobal.com

Comments0

300

Comments0

[LATEST] Latest Stories

  • Pfizer Ends Obesity Drug Trial After Liver Risk Emerges
  • Not Just Old Age: The Pneumonia That Affected Pope Francis’ Final Years
  • China Just Cranked U.S. Tariffs to 84% — And That’s Not the End of It
  • BMW's Next-Gen EV: The Bold New i3 Touring Concept Revealed
  • LEGO Technic Ferrari SF-24 F1 Car: A 1,361-Piece Tribute to Ferrari’s 2024 F1 Season
  • Hyundai’s Ioniq 6 Just Took the Top Spot in J.D. Power’s EV Ownership Study

You May Also Like

  • 1
    Are Food Additives Bad? Here’s What You Need to Know

    LIFESTYLE 

  • 2
    How Vitamin D Could Help Lower Colon Cancer Risk

    LIFESTYLE 

  • 3
    Yes, IVF Can Cause Weight Gain — Here's Why You Shouldn't Panic

    LIFESTYLE 

  • 4
    Red Jewels for Your Health: 7 Amazing Benefits of Pomegranates

    LIFESTYLE 

  • 5
    Hidden Danger: 5 'Healthy Foods' That Can Worsen Gout

    LIFESTYLE 

Popular Now

  • 1
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

  • 2
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE 

  • 3
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE 

  • 4
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE 

  • 5
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE 

Must-Reads

  • 1
    Are Food Additives Bad? Here’s What You Need to Know

    LIFESTYLE 

  • 2
    How Vitamin D Could Help Lower Colon Cancer Risk

    LIFESTYLE 

  • 3
    Yes, IVF Can Cause Weight Gain — Here's Why You Shouldn't Panic

    LIFESTYLE 

  • 4
    Red Jewels for Your Health: 7 Amazing Benefits of Pomegranates

    LIFESTYLE 

  • 5
    Hidden Danger: 5 'Healthy Foods' That Can Worsen Gout

    LIFESTYLE 

Popular Now

  • 1
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

  • 2
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE 

  • 3
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE 

  • 4
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE 

  • 5
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE 

Share it on...